DVAX — Dynavax Technologies Share News
0.000.00%
- $1.76bn
- $1.38bn
- $277.25m
U.S. STOCKS ON THE MOVE-Gilead Sciences, Instacart, Sarepta Therapeutics
Dynavax rises after its shingles vaccine shows similar immune response to GSK's shot in study
Dynavax's shingles vaccine shows similar immune response to GSK's shot in study
Brief: Dynavax Says Z-1018 Showed Lower Solicited Local & Systemic Post-Injection Reactions Vs Shingrix In Study
Dynavax Technologies Corp reports results for the quarter ended June 30 - Earnings Summary
Dynavax Technologies beats Q2 revenue expectations
US FDA approves pre-filled version of GSK's shingles vaccine
Brief: Dynavax Stockholders Elect All Dynavax Director Nominees At 2025 Annual Meeting
Dynavax elects all four of its nominees after Deep Track proxy fight (updated)
Dynavax investors re-elect all four nominees after board fight
Brief: Deep Track Capital Sends Letter To Dynavax Technologies Shareholders
Glass Lewis backs two of Deep Track's four nominees in Dynavax fight
ISS backs Dynavax directors in board fight with Deep Track Capital (updated)
ISS backs Dynavax directors in board fight with Deep Track Capital
Brief: Deep Track Capital Urges Dynavax Shareholders To Vote For Deep Track's Four Director Nominees
Brief: Dynavax Issues Statement And Mails Letter To Stockholders Emphasizing Record Financial Results And Continued Momentum
Dynavax Technologies Corp reports results for the quarter ended March 31 - Earnings Summary
Brief: Deep Track Capital Urges Dynavax Technologies Corp Shareholders To Vote For Deep Track's Four Highly Qualified Director Nominees
Brief: Dynavax Technologies Corp - Urges Stockholders To Vote 'For' All Four Co's Director Nominees